ethyl group is expensive and requires harsh deprotection
conditions (40% of HF at 70 °C for 1.5 h).4a Alternatively,
amine or amide nitrogens can be protected using a
benzhydryl group. A literature search indicates that only
two papers have employed the use of a benzhydryl group
for protection of uracil analogues. Martinez et al.8 at-
tempted to use the benzhydryl group to protect both the
N1 and N3 positions of 5-nitrouracil but failed because
of unsuccessful deprotection. Odijk et al.9 employed the
benzhydryl group to selectively protect the N1 position
of 5-fluorouracil. The benzhydryl group was introduced
in a low yield (40%) by converting 5-flurouracil into its
anion (NaH/HMPT) and then reacting with benzhydryl
chloride. The removal of the benzhydryl group was
performed with palladium-catalyzed hydrogenation (3-4
atm) but proved to be inefficient and highly sensitive to
the hydrogenation procedure. Herein, we report our
studies on the use of the benzhydryl group as an efficient
protecting group for uracil and uracil analogues and
illustrate its application by the preparation of uracil
analogues monobenzylated at the less active nitrogen.
Direct introduction of the benzhydryl group using the
sodium salt of uracil or uracil analogues and benzhydryl
bromide gave the monoprotected products in low yield,
along with disubstituted uracils and the starting materi-
als. However, monobenzhydrylated uracil analogues could
be conveniently and regioselectivity prepared in excellent
yield by the reaction of a uracil analogue with bis-
(trimethylsilyl)actamide (BSA) in acetonitrile, followed
by treatment with benzhydryl bromide in the presence
Benzhydryl as an Efficient Selective
Nitrogen Protecting Group for Uracils
Fan Wu,†,‡ Musole G. Buhendwa,† and
Donald F. Weaver*,†,‡,§
Departments of Chemistry and Medicine (Neurology) and
School of Biomedical Engineering, Dalhousie University,
Halifax, Nova Scotia, Canada B4H 4J3
Received August 25, 2004
Abstract: Regioselective N-substitution of the less active
nitrogen within uracil analogues has been achieved following
preliminary N-protection at the more active N-position with
a benzhydryl protecting group. This protecting group is
stable to concentrated HCl (aqueous) at reflux temperature,
TFA at room temperature, and Pd-C-catalyzed normal
pressure hydrogenation at room temperature; the benzhy-
dryl group can be removed quantitatively and selectively
with a 10% triflic acid solution in TFA at 0 °C.
Direct substitution at the nitrogen positions of uracil
analogues may yield the disubstituted product, the
product monosubstituted at the more active N-position,
or a complex mixture of mono- and disubstituted prod-
ucts. Selective protection/deprotection of the more active
nitrogen is critical for the synthesis of uracil analogues
monosubstituted at the less active nitrogen. A number
of protecting groups have been proposed and used for the
protection of endocyclic nitrogen atoms within uracils:
acyl,1 benzyl,2 p-methoxylbenzyl (PMB),3 alkoxymethyl,4
alkoxycarbonyl,5 and benzyloxycarbonyloxymethyl.6 How-
ever, these protecting groups suffer significant limita-
tions. For example, acyl-protected uracil analogues are
susceptible to the ongoing reaction conditions, the benzyl
group requires demanding reaction conditions for re-
moval,7 tert-butoxylcarbonyl (BOC)-protected uracil ana-
logues are very labile (and the introduction of BOC to
5-nitrouracil failed),5 and the bis(trimethylsiloxy)ethoxym-
of a catalytic amount of I2
or tetrabutylammonium iodide
(Scheme 1).10 The results are summarized in Table 1. The
position of benzhydrylation was dependent on the steric
properties at the uracil C6 position. If C6 is hydrogen,
the benzhydryl group was introduced at the less sterically
hindered N1 position; otherwise, the benzhydryl group
was introduced at the N3 position. The regiochemistry
of these derivatives was assessed by NOE experiments.
Reaction of benzhydryl-protected uracils 2a-h with
benzyl bromide in DMF in the presence of potassium
carbonate gave benzylated derivatives 3a-h in excellent
yield,11 as shown in Table 1.
† Department of Chemistry.
Reports on removal of the benzhydryl group from an
‡ Department of Medicine (Neurology).
amide nitrogen are limited. Martinez8 failed in the
§ School of Biomedical Engineering.
(1) Cruickshank, K. A.; Jiricny, J.; Reese, C. B. Tetrahedron Lett.
1984, 25, 681.
(2) Kundu, N. G.; Hertzberg, R. P.; Hannon, S. J. Tetrahedron Lett.
1980, 21, 1109.
(8) Martinez, A. P.; Lee, W. W.; Goodman, L. J. Med. Chem. 1968,
11 (2), 384.
(9) Odijk W. M.; Wanner, M. J.; Kooman, G. J.; Pandit, U. K.
Heterocycles 1978, 9 (10), 1403.
(3) Takaku, H.; Kamaike, K.; Tsuchiya, J. J. Org. Chem. 1984, 49,
51.
(4) (a) Arias, L.; Guzma´n, A.; Jaime-Figueroa, S.; Lopez, F. J.;
Morgans, D. J., Jr.; Padilla, F.; Pe´rez-Medrano, A.; Quintero, C.;
Romero, M.; Sandoval, L. Synlett 1997, 1233. (b) Kundu, N. G.; Khatri,
S. G. Synthesis 1985, 323. (c) Ito, T.; Ueda, S.; Takaku, H. J. Org.
Chem. 1986, 51, 931. (d) Kishi, Y.; Nakatsuka, S.; Fukuyama, T.;
Mavel, M. J. Am. Chem. Soc. 1973, 95, 6493. (e) Fukuyama, T.;
Nakatsuka, S.; Kishi, Y. Tetrahedron 1981, 37, 2045. (f) Nakatsuka,
S.; Miyszaki, H.; Goto, T. Tetrahedron Lett. 1980, 21, 2817.
(5) Jaime-Figueroa, S.; Zamilpa, A.; Guzma´n, A.; Morgans, D. J.,
Jr. Synth. Commun. 2001, 31, 3739.
(10) Representative Procedure. To a suspension of thymine 1b
(1.26 g, 10.0 mmol) in acetonitrile (30 mL) was added bis(trimethyl-
silyl)actamide (6.2 mL, 25 mmol) under argon. After the reaction
mixture became a clear solution (in several minutes), benzhydryl
bromide (3.71 g, 15.0 mmol) and a catalytic amount of I2 were added.
The reaction solution was heated at reflux until all starting material
was consumed. After cooling to room temperature, the mixture was
concentrated on a rotary evaporator, diluted with 100 mL of ethyl
acetate, and washed with 50 mL of H2O. The organic phase was dried
over Na2SO4 and evaporated to dryness. The residue was purified by
flash chromatography (hexane/ethyl acetate ) 3:2) to give 1-benzhy-
(6) Nagase, T.; Seike, K.; Shiraishi, K.; Yamada, Y.; Ozaki, S. Chem.
Lett. 1988, 8, 1381.
drylthymine 2b (2.78 g, 95%) as a white powder: mp 226-227 °C; 1
H
(7) (a) Mueller, C. E.; Thorand, M.; Qurishi, R.; Diekmann, M.;
Jacobson, K. A.; Padgett, W. L.; Daly, J. W. J. Med. Chem. 2002, 45
(16), 3440. (b) Philips, K. D.; Horwitz, J. P. J. Org. Chem. 1975, 40,
1856. (c) Philips K. D.; Horwitz, J. P. J. Org. Chem. 1975, 40, 1856.
NMR (500 MHz, DMSO) δ 1.71 (d, J ) 0.69 Hz, 3H), 6.94 (s, 1H), 7.16-
7.43 (m, 11H), 11.43 (s, 1H); 13C NMR (125 MHz, DMSO) δ 12.1, 61.0,
109.3, 127.9, 128.3, 128.8, 137.9, 138.2, 151.0, 163.6; HRMS calcd for
C18H16N2O2 292.1212, found 292.1211.
10.1021/jo0485076 CCC: $27.50 © 2004 American Chemical Society
Published on Web 11/17/2004
J. Org. Chem. 2004, 69, 9307-9309
9307